Deal Ends TodayยทSave 35% annual plan
GLP-1 receptor agonistReviewed for 2026 plan year

Does Anthem Cover Wegovy?

The verdict

Conditional on most plans

Anthem (Elevance) covers Wegovy for weight loss on commercial plans only when the employer opts into the anti-obesity benefit via CarelonRx; without that opt-in, weight-loss coverage is excluded regardless of medical need. Medicare Advantage plans cover Wegovy only for the cardiovascular risk-reduction indication. Medicaid coverage varies by state.

MedicareConditional
CommercialConditional
See the difference

Coverage is set by your specific plan and formulary. This is a research summary โ€” always confirm with Anthem using your member ID.

Reviewed for 2026
Checked against the active plan year
Sourced from formularies
Anthem drug lists + CMS guidance
Updated as rules change
Coverage and prior-auth criteria shift often
Verify before you decide
Informational only โ€” not insurance advice

Key facts

  • Anthem requires at least 5% baseline weight loss for Wegovy reauthorization โ€” a concrete renewal threshold few competitor pages mention.

    MMIT / industry formulary data via GoodRx

  • Wegovy's list price is $1,349/month; Novo Nordisk has announced a cut to approximately $675/month effective January 1, 2027.

    Novo Nordisk press release, 2026

  • The Medicare GLP-1 Bridge launches July 1, 2026, giving eligible beneficiaries Wegovy weight-loss access at $50/month โ€” outside Part D, not counting toward the $2,100 OOP cap.

    CMS.gov, Medicare GLP-1 Bridge announcement

Plan types

Medicare vs. commercial coverage

Whether Anthem covers Wegovy depends heavily on which kind of plan you hold. They follow completely different rules โ€” here's each one, side by side.

Medicare

Part D & Advantage plans

Conditional

Medicare Part D cannot cover Wegovy for weight loss by statute โ€” this applies to all Anthem Medicare Advantage and standalone Part D plans. Anthem Medicare plans can cover Wegovy for the cardiovascular risk-reduction indication (FDA-approved for adults with established CVD who are overweight or obese) with prior authorization. Separately, the Medicare GLP-1 Bridge launches July 1, 2026, giving eligible beneficiaries weight-loss access to Wegovy at $50/month through December 31, 2027 โ€” this operates outside Part D, so the $50 does not count toward the $2,100 OOP cap or TrOOP. Extra Help cannot be applied to Bridge copays. NovoCare savings card is not available to Medicare beneficiaries.

Commercial / Employer

Group & marketplace plans

Conditional

Anthem commercial and employer plans cover Wegovy for weight loss only when the employer has purchased the anti-obesity benefit through CarelonRx (Anthem's PBM). Where covered, Wegovy is placed on a specialty tier and requires prior authorization: BMI 30 or higher, or BMI 27 or higher with a weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea), plus documented participation in a lifestyle or weight-management program. A critical renewal criterion: at least 5% baseline weight loss must be demonstrated for Anthem to reauthorize the prescription. If the employer did not opt into anti-obesity drug coverage, no amount of PA paperwork will succeed โ€” this is a benefit exclusion, not a medical-necessity denial, and is not appealable. ACA/individual-market Anthem plans generally exclude Wegovy for weight loss. State-employee plans are not treated as government programs for the NovoCare savings offer, so members with plan coverage may use the $25/month NovoCare savings card (max $100 per 28-day supply).

Prior authorization

The 5 boxes you must tick to get approved

Commercial plans that will consider Wegovy require prior authorization. Check off what applies to you to see how close you are โ€” this is a guide, not a guarantee of approval.

Requirements you meet0 / 5

Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.

What you'll pay

Your cost, three ways

What Wegovy actually costs you swings enormously depending on how it's covered. Here's the realistic range.

No coverage

Paying cash

$1,349/month (Novo Nordisk published list price for a 28-day supply). NovoCare self-pay: approximately $349/month for standard injection doses after an introductory period.

List price with no coverage โ€” before any manufacturer savings card.

PA approved

With coverage

Specialty-tier cost-share is plan-specific and varies by deductible, tier, and phase. Confirm your specific cost-share on Anthem's drug-lookup tool or member portal. NovoCare savings card: commercially insured members whose plan covers Wegovy may pay as little as $25/month (max $100 per 28-day supply). Not available to Medicare or Medicaid beneficiaries.

Typical monthly copay once prior authorization is approved.

Lowest cost

Bridge program

Medicare GLP-1 Bridge: $50/month fixed copay for eligible Medicare beneficiaries, launching July 1, 2026, through December 31, 2027. Operates outside Part D โ€” does not count toward the $2,100 OOP cap, TrOOP, or Extra Help. Provider must attest eligibility at initiation.

Reduced copay through the assistance program, where eligible.

All cost figures are estimates. Actual cost-share varies by plan tier, deductible phase, and pharmacy โ€” confirm with your Anthem plan and pharmacist before starting treatment.

Do it yourself

Check YOUR exact coverage in 3 steps

General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.

  1. 1

    Check your employer's benefit design first

    Before searching formularies, ask your HR benefits team whether anti-obesity medications are included in your plan. If they are carved out, no formulary lookup or PA will change that โ€” it is a benefit exclusion. This step alone can save weeks of paperwork.

  2. 2

    Search Anthem's drug-lookup tool

    Go to anthem.com and use the drug-lookup or formulary search tool with your specific plan ID. Search for 'Wegovy' or 'semaglutide 2.4 mg' to confirm tier, PA requirements, and quantity limits for your actual plan.

  3. 3

    Work with your prescriber on prior authorization

    If your plan covers Wegovy, your doctor will submit a PA through CarelonRx. Gather documentation: BMI measurement, relevant comorbidities, and evidence of a lifestyle program. Keep track of your weight-loss progress โ€” Anthem requires at least 5% weight loss to renew the authorization.

If it's denied

Options if Anthem won't cover Wegovy

A denial isn't the end of the road. These are the paths people commonly explore next โ€” discuss any of them with your prescriber.

Ozempic (semaglutide for T2D)

If you have type 2 diabetes, Anthem broadly covers Ozempic through CarelonRx regardless of employer anti-obesity benefit design. Ozempic is not FDA-approved for weight loss and should not be prescribed for that indication.

NovoCare self-pay program

Novo Nordisk's NovoCare Pharmacy offers Wegovy at approximately $349/month for patients without coverage. An introductory rate of approximately $199/month applies to the 0.25 and 0.5 mg doses through December 31, 2026. List price drops to approximately $675/month effective January 1, 2027.

Compounded semaglutide

Compounded semaglutide is available without insurance for patients who cannot access covered Wegovy. See the Curex offer below. Compounded medications are not the same as Wegovy and have not been approved by the FDA.

These options are listed for information only โ€” your own clinician decides what is appropriate for you.

โ“Frequently Asked Questions

Anthem covers Wegovy for weight loss only on commercial/employer plans where the employer has opted into the anti-obesity benefit through CarelonRx. Without that benefit, weight-loss coverage is excluded โ€” it is a benefit design decision, not a medical-necessity one. If your employer did include the benefit, you will need a prior authorization demonstrating BMI 30 or higher (or 27 with a comorbidity) and a documented lifestyle program, and you must show at least 5% weight loss to renew. Verify on Anthem's drug-lookup tool or ask HR.

Ozempic is FDA-approved for type 2 diabetes, so Anthem covers it for that indication regardless of employer benefit design. Wegovy is FDA-approved for weight management, which insurers classify as an anti-obesity benefit โ€” a separate, optional benefit layer that employers must purchase. Same molecule, different FDA indications, different coverage logic. This is the clearest example of how on-label indication, not drug brand, drives coverage.

Anthem and CarelonRx require that a member demonstrate at least 5% baseline weight loss to reauthorize a Wegovy prescription at renewal. This means if you started at 200 pounds, you need to have lost at least 10 pounds. The rule applies even if the medication is well-tolerated and beneficial in other health measures. Plan ahead with your prescriber to document progress before your renewal date to avoid a gap in coverage.

No. Medicare Part D, which underlies all Anthem Medicare Advantage plans, cannot cover Wegovy for weight loss by statute โ€” this is a federal law, not an Anthem policy decision. Anthem Medicare Advantage plans can cover Wegovy for the cardiovascular risk-reduction indication in members with established CVD. The Medicare GLP-1 Bridge (launching July 1, 2026) provides weight-loss access at $50/month outside Part D for eligible Medicare beneficiaries โ€” verify eligibility criteria with your prescriber.

Commercially insured Anthem members whose plan covers Wegovy may use the NovoCare savings card to pay as little as $25/month (up to $100 savings per 28-day supply). The card is not available to Medicare or Medicaid beneficiaries due to federal anti-kickback rules. State-employee plans on Anthem are treated as commercial plans for this offer, so those members may use the card if their plan covers Wegovy.

If your employer carved out anti-obesity medications, Wegovy for weight loss is a benefit exclusion โ€” it will not be covered no matter how strong the medical justification, and a standard PA appeal will not succeed. Your options are: self-pay via NovoCare (approximately $349/month), the Medicare Bridge if you have qualifying Medicare (from July 1, 2026), or the cardiovascular indication if you have established CVD. Discuss self-pay alternatives with your prescriber.

The Curex GLP-1 program

Whether or not Anthem covers Wegovy, there's a path that skips insurance

Anthem covers Wegovy for weight loss only if your employer opted in, and requires at least 5% weight loss to renew. For patients without that benefit, Curex offers compounded semaglutide from $49/mo (compounded tirzepatide from $149/mo) โ€” no insurance, no prior authorization. Compounded semaglutide is not the same medication as Wegovy. Prescription required, subject to provider review.

Compounded semaglutide
from$49/mo
Weekly injection or oral tablet
Compounded tirzepatide
from$149/mo
Injection or oral tablet
  • Medication + free shipping
  • 24/7 provider access
  • Medical intake & prescription review
From $49/moNo insurance requiredNo prior auth
Build your personalized planPrescription required, subject to provider review.

Compounded semaglutide and tirzepatide are not the same medications as Wegovy and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.

This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date โ€” always verify current benefits directly with Anthem before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Wegovy and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.

Weight care with Curex

Whether or not Anthem covers Wegovy, there's a path that skips insurance

Build your personalized plan

Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.